KIRREL promotes the proliferation of gastric cancer cells and angiogenesis through the PI3K/AKT/mTOR pathway
出版年份 2023 全文链接
标题
KIRREL promotes the proliferation of gastric cancer cells and angiogenesis through the PI3K/AKT/mTOR pathway
作者
关键词
-
出版物
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-11-01
DOI
10.1111/jcmm.18020
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Surgical Management of Gastric Cancer
- (2022) George Z. Li et al. JAMA Surgery
- PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
- (2022) Yan Peng et al. Frontiers in Oncology
- Novel Drugs with High Efficacy against Tumor Angiogenesis
- (2022) Shiyu Qi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrated screens uncover a cell surface tumor suppressor gene KIRREL involved in Hippo pathway
- (2022) Chao Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Current treatment and recent progress in gastric cancer
- (2021) Smita S. Joshi et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
- (2021) Wei Cao et al. CHINESE MEDICAL JOURNAL
- Insulin and the insulin receptor collaborate to promote human gastric cancer
- (2021) Marina Saisana et al. Gastric Cancer
- Phosphorylation of slit diaphragm proteins NEPHRIN and NEPH1 upon binding of HGF promotes podocyte repair
- (2021) Ashish K. Solanki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
- (2021) Feng‐Hua Wang et al. Cancer Communications
- VEGF inhibition in urothelial cancer: the past, present and future
- (2020) Sanaz Ghafouri et al. WORLD JOURNAL OF UROLOGY
- Overexpression of kin of IRRE-Like protein 1 (KIRREL) as a prognostic biomarker for breast cancer
- (2020) Kexin Chen et al. PATHOLOGY RESEARCH AND PRACTICE
- Gastric cancer: a comprehensive review of current and future treatment strategies
- (2020) Rachel E. Sexton et al. CANCER AND METASTASIS REVIEWS
- First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
- (2020) Hyun Cheol Chung et al. Future Oncology
- Vessel co-option in cancer
- (2019) Elizabeth A. Kuczynski et al. Nature Reviews Clinical Oncology
- Disruption of the exocyst induces podocyte loss and dysfunction
- (2019) Deepak Nihalani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Updates on Management of Gastric Cancer
- (2019) Fabian M. Johnston et al. Current Oncology Reports
- Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
- (2019) Raluca Ioana Teleanu et al. Journal of Clinical Medicine
- Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
- (2018) Jin Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
- (2018) Kabir A. Khan et al. Nature Reviews Clinical Oncology
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression of Kin of IRRE-Like Protein 1 (KIRREL) in Gastric Cancer and Its Clinical Prognostic Significance
- (2018) Ming-Jun Zhang et al. MEDICAL SCIENCE MONITOR
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells
- (2017) Pol Gimenez-Xavier et al. MOLECULAR CANCER THERAPEUTICS
- CpG methylation patterns are associated with gene expression variation in osteosarcoma
- (2017) Qiang Wang Molecular Medicine Reports
- Progress in the treatment of advanced gastric cancer
- (2017) Zheyu Song et al. TUMOR BIOLOGY
- Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials
- (2016) Fei Shan et al. CANCER LETTERS
- Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination
- (2016) Jason S. L. Yu et al. DEVELOPMENT
- Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
- (2016) Naomi B Haas et al. LANCET
- Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation
- (2016) Marina Saisana et al. Oncotarget
- Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer
- (2016) Youliang Wu et al. Oncotarget
- CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer
- (2015) Zhe-Wei Wei et al. CANCER LETTERS
- Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing
- (2015) Charles Walther et al. LABORATORY INVESTIGATION
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
- (2015) Andrew X Zhu et al. LANCET ONCOLOGY
- Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
- (2015) Josep Tabernero et al. LANCET ONCOLOGY
- Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation
- (2015) Peter W. Hewett et al. THROMBOSIS AND HAEMOSTASIS
- Signal Transduction in Cancer
- (2015) R. Sever et al. Cold Spring Harbor Perspectives in Medicine
- PI3K/AKT signaling pathway and cancer: an updated review
- (2014) Miriam Martini et al. ANNALS OF MEDICINE
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance
- (2014) Oscar Tapia et al. VIRCHOWS ARCHIV
- Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
- (2014) Vladimir Riabov et al. Frontiers in Physiology
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
- (2012) Jaafar Bennouna et al. LANCET ONCOLOGY
- Cancer prevention by targeting angiogenesis
- (2012) Adriana Albini et al. Nature Reviews Clinical Oncology
- An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
- (2011) M. Moehler et al. EUROPEAN JOURNAL OF CANCER
- Phase II Study of Sorafenib in Combination With Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: ECOG 5203
- (2010) Weijing Sun et al. JOURNAL OF CLINICAL ONCOLOGY
- The insect nephrocyte is a podocyte-like cell with a filtration slit diaphragm
- (2008) Helen Weavers et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now